5 unknown, 3 completed, 2 not yet recruiting, 2 recruiting. 5 Phase 2, 3 Phase 1, 2 Not applicable, 1 Early Phase 1, 1 Phase 3.
Follow CMV Viremia: new trials by email Literature Review of CMV Viremia trials Research Report on CMV Viremia
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| 25BT056: Basket Study of Viral Cytotoxic T Lymphocytes Virus-Specific Cytotoxic T Lymphocytes (vCTLs) - EBV Viremia, CMV Viremia | Early Phase 1 | Not yet recruiting | Children's Hospital of Philadelphia | 35 | 2026-11-01 | 2026-10-22 |
| Trial to Study Anti- HCMV Therapy in Breast Cancer Patients With Progressive Intracranial Metastases and CMV Infection Valganciclovir - Brain Cancer Metastatic, CMV Viremia | Phase 2 | Recruiting | The Methodist Hospital Research Institute | 28 | 2026-07-14 | 2026-08-10 |
| Letermovir vs Valganciclovir in CMV R+ Kidney Transplant Letermovir, Valganciclovir CMV Prophylaxis - CMV Infection, CMV | Phase 4 | Not yet recruiting | Elisabeth Kincaide | 300 | 2026-05-01 | 2026-05-08 |
| Valganciclovir vs. Letermovir for CMV Prophylaxis in Heart Transplant Letermovir, Valganciclovir - CMV Viremia, Heart Transplant Infection | Phase 2 / Phase 3 | Recruiting | Columbia University | 150 | 2025-09-12 | 2026-10-02 |
| Expansion of Virus-Specific Lymphocytes for Cell Therapy Lymphocyte infusion (ImmuneCellVir-I) - CMV Viremia, CMV | Phase 1 | Unknown | Hospital Israelita Albert Einstein | 10 | 2024-06-10 | 2024-10-24 |
| Real-world CMV Outcomes Among Kidney Transplant Recipients in Brazil CMV Infection, CMV Viremia | Unknown | Hospital do Rim e Hipertensão | 500 | 2023-10-01 | 2024-02-22 | |
| Cytomegalovirus Prophylaxis With Letermovir in Heart Transplant Recipients Letermovir Pill - CMV Viremia | Phase 2 | Unknown | University Medical Centre Ljubljana | 90 | 2023-05-01 | 2023-11-09 |
| Cytomegalovirus (CMV) Vaccines: Reinfection and Antigenic Variation Women Enrolled, Newborns of Female Study Participants - Cmv Congenital, CMV Viremia | Not applicable | Completed | University of Alabama at Birmingham | 121 | 2022-09-01 | 2026-10-07 |
| CMV Infection and Immune Intervention After Transplantation expanded NK cells - CMV Viremia, Transplantation Infection | Not applicable | Unknown | Peking University People's Hospital | 30 | 2020-03-23 | 2021-06-11 |
| Treatment of Cytomegalovirus (CMV) Infections With Viral-Specific T Cells CMV-specific T-cells - CMV Infection, Cytomegalovirus Infections | Phase 1 | Terminated | University of Wisconsin, Madison | 3 | 2020-02-06 | 2024-10-31 |
| The Molecular Mechanism of CMV-driven NKG2C+NK Cell Expansion in Human Acute Leukemia, CMV Viremia | Unknown | Peking University People's Hospital | 40 | 2020-01-01 | 2020-10-01 | |
| Virus-specific Activated T Lymphocytes From a Donor in Hematopoietic Progenitor Transplanted Patients Activated T-Lymphocytes - CMV Viremia, Immunosuppression-related Infectious Disease | Phase 1 / Phase 2 | Completed | Banc de Sang i Teixits | 26 | 2019-07-04 | 2024-01-24 |
| Treating Kidney Donors With Valganciclovir to Reduce Viral Transmission to Recipients Valganciclovir, Placebo - EBV Viremia, CMV Viremia | Phase 2 | Completed | University of Minnesota | 17 | 2011-06-01 | 2019-11-01 |
| Expanded Access Protocol of ATA230 (Third-Party Donor-Derived CMV-CTLs) for the Treatment of CMV Viremia or Disease Cytomegalovirus-specific Cytotoxic T Lymphocytes (CMV-CTLs) - CMV Viremia, CMV Disease | No longer available | Atara Biotherapeutics | 2019-04-08 |
Cytomegalovirus Infections (5) · Virus Diseases (2) · Acquired Immunodeficiency Syndrome (1) · Adenoviridae Infections (1) · Brain Neoplasms (1) · Communicable Diseases (1) · Epstein-Barr Virus Infections (1) · Neutropenia (1) · Opportunistic Infections (1) · Primary Immunodeficiency Diseases (1) · Rejection, Psychology (1) · Severe Combined Immunodeficiency (1) · Viremia (1)
Infections (7) · DNA Virus Infections (6) · Herpesviridae Infections (6) · Virus Diseases (5) · Immune System Diseases (2) · Immunologic Deficiency Syndromes (2) · Pathologic Processes (2) · Pathological Conditions, Signs and Symptoms (2) · Agranulocytosis (1) · Behavior (1) · Blood-Borne Infections (1) · Brain Diseases (1) · Central Nervous System Diseases (1) · Central Nervous System Neoplasms (1) · Communicable Diseases (1)
Valganciclovir (3) · letermovir (3)
Peking University People's Hospital (2) · Atara Biotherapeutics (1) · Banc de Sang i Teixits (1) · Children's Hospital of Philadelphia (1) · Columbia University (1) · Elisabeth Kincaide (1) · Hospital Israelita Albert Einstein (1) · Hospital do Rim e Hipertensão (1) · The Methodist Hospital Research Institute (1) · University Medical Centre Ljubljana (1) · University of Alabama at Birmingham (1) · University of Minnesota (1) · University of Wisconsin, Madison (1)
United States (5) · Brazil (3) · China (2) · Slovenia (1) · Spain (1)
Akshjot Puri, M.D. (1) · Bojan Vrtovec, MD, PhD (1) · Caitlin Elgarten, MD, MSCE (1) · Christain Capitini, MD (1) · Jacques Galipeau, MD (1) · Nelson Hamerschlak, MD, PhD (1) · Pere Barba, MD, PhD (1) · Priya Verghese, MD, MPH (1) · William J. Britt, MD (1) · Willis Navarro, MD (1) · Xiaojun Huang, M.D., PhD (1)
R01HD061959 (1)